Tiziana Life Sciences Ltd (FRA:0RP)
Germany
· Delayed Price · Currency is EUR 1.470
+0.040 (2.80%)
Last updated: Dec 5, 2025, 8:02 AM CET
Tiziana Life Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -12.84 | -11.86 | -17.69 | -15.4 | -23.42 | -26.13 | Upgrade
|
| Depreciation & Amortization | 0.15 | 0.12 | 0.1 | 0.05 | 0.14 | 0.09 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.41 | 0 | - | 0.13 | -0.03 | -2.66 | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.44 | 1.76 | 0.4 | 0.87 | - | 0.3 | Upgrade
|
| Stock-Based Compensation | 8.04 | 5.97 | 2.3 | 1.81 | 6.03 | 19.07 | Upgrade
|
| Other Operating Activities | 2.69 | 3.04 | 0.78 | -5.91 | -3.71 | -1.7 | Upgrade
|
| Change in Accounts Receivable | -2.03 | -1.47 | -1.52 | -1.16 | -0.09 | -0.03 | Upgrade
|
| Change in Accounts Payable | - | - | - | -1.36 | -0.69 | 1.15 | Upgrade
|
| Change in Other Net Operating Assets | -1.91 | 0.92 | -0.06 | 1.35 | - | -1.41 | Upgrade
|
| Operating Cash Flow | -8.75 | -1.53 | -15.7 | -19.62 | -21.76 | -11.34 | Upgrade
|
| Capital Expenditures | -0.01 | -0.02 | - | - | -0.02 | -0 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | - | -0.12 | Upgrade
|
| Investment in Securities | 2.89 | - | -1 | -2.68 | - | - | Upgrade
|
| Investing Cash Flow | 2.88 | -0.02 | -1 | -2.68 | 0.13 | -0.12 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 0.16 | Upgrade
|
| Total Debt Issued | - | - | - | - | - | 0.16 | Upgrade
|
| Long-Term Debt Repaid | - | -0.14 | -0.12 | -0.06 | -0.15 | -0.28 | Upgrade
|
| Net Debt Issued (Repaid) | -0.12 | -0.14 | -0.12 | -0.06 | -0.15 | -0.11 | Upgrade
|
| Issuance of Common Stock | 12.05 | 4.65 | 0.02 | - | - | 71.16 | Upgrade
|
| Repurchase of Common Stock | -0.05 | -0.05 | -0.25 | -1.32 | - | - | Upgrade
|
| Other Financing Activities | - | - | 0.14 | - | 0.13 | 4.3 | Upgrade
|
| Financing Cash Flow | 11.88 | 4.45 | -0.21 | -1.38 | -0.02 | 75.35 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.11 | -0.37 | -0.03 | -0.4 | -1.98 | 1.74 | Upgrade
|
| Net Cash Flow | 6.12 | 2.54 | -16.94 | -24.06 | -23.64 | 65.62 | Upgrade
|
| Free Cash Flow | -8.76 | -1.55 | -15.7 | -19.62 | -21.78 | -11.34 | Upgrade
|
| Free Cash Flow Per Share | -0.08 | -0.01 | -0.15 | -0.19 | -0.22 | -0.12 | Upgrade
|
| Cash Income Tax Paid | - | -8.78 | - | -0.49 | -1.42 | - | Upgrade
|
| Levered Free Cash Flow | -3.86 | -0.59 | -8.99 | -7.93 | -13.38 | -2.58 | Upgrade
|
| Unlevered Free Cash Flow | -3.86 | -0.59 | -8.98 | -7.93 | -13.27 | -2.38 | Upgrade
|
| Change in Working Capital | -3.93 | -0.55 | -1.58 | -1.16 | -0.77 | -0.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.